Document Detail


Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line.
MedLine Citation:
PMID:  21082187     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
INTRODUCTION: Inhibins, dimeric peptide hormones composed of an alpha-subunit and one of two possible beta-subunits (betaA or betaB), exhibit substantial roles in human reproduction and in endocrine-responsive tumors. However, it is still unclear if normal and cancerous cervical glandular epithelial cells as well as cervical cancer cell lines of glandular origin express the inhibin-betaA and -betaB subunits.
MATERIALS AND METHODS: Normal cervical tissue samples and a total of 10 specimens of well-differentiated adenocarcinomas of the human cervix were analyzed for inhibin-betaA and -betaB subunit expression by immunohistochemical analysis. Additionally, the cervical carcinoma cell line HeLa was analyzed by immunofluorescence and RT-PCR analysis for the expression of inhibin subunits.
RESULTS: Immunolabeling of normal and malignant glandular epithelium of human cervical tissue revealed a positive staining reaction for the inhibin-betaA and -betaB subunits. Additionally, the cancer cell line HeLa synthesized both inhibin subunits. When compared to the normal cervical glandular epithelium, the expression of the inhibin beta subunits became significantly reduced in cervical adenocarcinoma tissues.
DISCUSSION: In conclusion, we demonstrated a strong, though differential expression pattern of inhibin-betaA and -betaB subunits in normal and malignant glandular epithelial cells of the human uterine cervix. Although the physiological role of inhibins is still quite unclear in cervical tissue, the expression of inhibin-beta-subunits might play an important role in cervical cancer carcinogenesis, since they are significantly down-regulated during pathogenesis in cervical adenocarcinomas.
Authors:
Alexander Burges; Naim Shabani; Ansgar Brüning; Ioannis Mylonas
Related Documents :
20206267 - P53 family members in cancer diagnosis and treatment.
11374847 - New molecular approaches to lung cancer: biological and clinical implications of p53, p...
12620387 - Candidate tumor suppressor genes at fra7g are coamplified with met and do not suppress ...
9565747 - Relationship of p53 and vascular endothelial growth factor expression of clinicopatholo...
21516307 - The biomechanical properties of 3d extracellular matrices and embedded cells regulate t...
7881457 - Neuropsychological changes in children with cancer: the treatment of missing data in lo...
Publication Detail:
Type:  Journal Article     Date:  2010-11-17
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  284     ISSN:  1432-0711     ISO Abbreviation:  Arch. Gynecol. Obstet.     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-09-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  981-8     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Ludwig-Maximilians-University Munich, Campus Großhadern, Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New emerging drugs targeting the genomic integrity and replication machinery in ovarian cancer.
Next Document:  Postextubation obstructive pseudomembranes: a case series and review of a rare complication after en...